The University of Chicago Header Logo

Ezra Cohen

Concepts (656)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Head and Neck Neoplasms
123
2024
1075
18.630
Why?
Carcinoma, Squamous Cell
89
2024
1089
13.260
Why?
Antineoplastic Agents
50
2024
2366
5.510
Why?
Antineoplastic Combined Chemotherapy Protocols
59
2023
2555
5.470
Why?
Neoplasm Recurrence, Local
46
2024
1395
5.190
Why?
Quinazolines
28
2019
214
4.900
Why?
ErbB Receptors
29
2021
498
4.130
Why?
Thyroid Neoplasms
16
2024
432
3.830
Why?
Protein Kinase Inhibitors
27
2024
596
3.710
Why?
Mouth Neoplasms
17
2024
199
3.260
Why?
Antibodies, Monoclonal, Humanized
25
2024
977
2.660
Why?
Chemoradiotherapy
21
2022
317
2.570
Why?
Cetuximab
15
2022
114
2.420
Why?
Biomarkers, Tumor
18
2025
1573
2.200
Why?
Neoplasms
26
2025
3123
2.100
Why?
Humans
218
2025
92134
1.800
Why?
Disease-Free Survival
36
2021
1179
1.740
Why?
Papillomavirus Infections
10
2022
271
1.670
Why?
Indazoles
8
2015
60
1.630
Why?
B7-H1 Antigen
10
2024
286
1.620
Why?
Oropharyngeal Neoplasms
6
2018
126
1.610
Why?
Imidazoles
8
2015
141
1.580
Why?
Aged
96
2025
19913
1.510
Why?
Immunotherapy
11
2024
723
1.500
Why?
Methotrexate
9
2019
245
1.400
Why?
Sirolimus
8
2018
173
1.390
Why?
TOR Serine-Threonine Kinases
10
2021
208
1.350
Why?
Carcinoma, Non-Small-Cell Lung
10
2024
1139
1.350
Why?
Programmed Cell Death 1 Receptor
10
2024
183
1.340
Why?
Middle Aged
96
2025
26991
1.330
Why?
Lung Neoplasms
12
2024
2394
1.290
Why?
Female
117
2025
47767
1.260
Why?
Indoles
9
2016
308
1.240
Why?
Anilides
6
2016
45
1.230
Why?
Antineoplastic Agents, Immunological
7
2020
215
1.210
Why?
Treatment Outcome
55
2025
8689
1.210
Why?
Male
108
2025
43796
1.170
Why?
Pyridines
8
2016
305
1.160
Why?
Molecular Targeted Therapy
12
2024
290
1.080
Why?
Adult
82
2024
27478
1.070
Why?
Aged, 80 and over
44
2021
6911
1.070
Why?
Neoplasm Metastasis
22
2024
1073
1.030
Why?
Protein-Tyrosine Kinases
6
2012
307
1.010
Why?
Neoplasm Staging
26
2019
2035
0.970
Why?
Quality of Life
13
2021
1740
0.950
Why?
Cisplatin
9
2022
602
0.940
Why?
Papillomaviridae
8
2024
165
0.880
Why?
Combined Modality Therapy
25
2020
1730
0.860
Why?
Drug Resistance, Neoplasm
7
2019
620
0.860
Why?
Induction Chemotherapy
11
2021
151
0.850
Why?
Everolimus
4
2022
35
0.840
Why?
Fluorocarbons
1
2023
71
0.830
Why?
Mutation
20
2024
4220
0.810
Why?
Salivary Gland Neoplasms
4
2020
77
0.800
Why?
Phenylurea Compounds
6
2015
96
0.750
Why?
Proto-Oncogene Proteins c-akt
7
2016
364
0.740
Why?
Survival Analysis
20
2020
1508
0.740
Why?
Skin Neoplasms
3
2022
605
0.740
Why?
Carcinoma, Papillary
4
2016
157
0.720
Why?
Antibodies, Monoclonal
10
2021
1407
0.700
Why?
Disease Management
4
2021
341
0.700
Why?
Precancerous Conditions
5
2024
202
0.680
Why?
Cell Line, Tumor
16
2021
2667
0.670
Why?
Laryngeal Neoplasms
4
2013
88
0.660
Why?
Nasopharyngeal Neoplasms
3
2015
47
0.660
Why?
Prognosis
21
2021
3860
0.650
Why?
Cancer Vaccines
1
2020
165
0.630
Why?
Vascular Endothelial Growth Factor A
6
2023
410
0.630
Why?
Signal Transduction
17
2021
3508
0.610
Why?
Angiogenesis Inhibitors
8
2023
297
0.610
Why?
Antigens, Neoplasm
1
2020
345
0.610
Why?
Kaplan-Meier Estimate
9
2018
864
0.600
Why?
Benzazepines
1
2018
65
0.600
Why?
Human papillomavirus 16
4
2019
38
0.600
Why?
Proto-Oncogene Proteins c-kit
2
2015
79
0.590
Why?
Survivors
2
2016
198
0.590
Why?
Quinolines
2
2015
88
0.570
Why?
Algorithms
3
2025
1943
0.560
Why?
Clinical Trials as Topic
10
2016
1148
0.560
Why?
Fluorouracil
15
2014
549
0.560
Why?
Killer Cells, Natural
2
2017
279
0.550
Why?
Patient Selection
8
2021
689
0.540
Why?
Research Design
5
2014
599
0.540
Why?
Survival Rate
12
2016
1919
0.530
Why?
Precision Medicine
4
2021
424
0.530
Why?
Hypopharyngeal Neoplasms
2
2013
15
0.520
Why?
Carcinoma, Adenoid Cystic
2
2015
41
0.510
Why?
Iodine Radioisotopes
5
2023
135
0.510
Why?
Dasatinib
1
2015
38
0.500
Why?
Tumor Microenvironment
7
2024
529
0.500
Why?
Drug Administration Schedule
8
2018
868
0.490
Why?
Erlotinib Hydrochloride
6
2016
88
0.490
Why?
Mice, Nude
8
2016
829
0.490
Why?
Antibody-Dependent Cell Cytotoxicity
1
2015
22
0.480
Why?
Practice Guidelines as Topic
4
2019
1077
0.480
Why?
Aftercare
1
2016
88
0.470
Why?
Glutamates
2
2012
89
0.470
Why?
Anticarcinogenic Agents
2
2016
73
0.470
Why?
Antibiotics, Antineoplastic
2
2012
111
0.470
Why?
Maximum Tolerated Dose
10
2017
268
0.460
Why?
Adaptor Proteins, Signal Transducing
4
2016
318
0.460
Why?
Receptors, Vascular Endothelial Growth Factor
6
2023
67
0.450
Why?
Guanine
2
2012
207
0.450
Why?
Palliative Care
2
2015
264
0.440
Why?
Neovascularization, Pathologic
3
2015
355
0.440
Why?
Radiodermatitis
1
2013
10
0.440
Why?
Pyrroles
4
2015
171
0.430
Why?
Mucositis
1
2013
17
0.430
Why?
Administration, Oral
9
2017
674
0.430
Why?
Neoplasm Invasiveness
4
2012
570
0.430
Why?
Radiopharmaceuticals
2
2015
193
0.430
Why?
Food-Drug Interactions
1
2013
19
0.420
Why?
Adenocarcinoma
4
2023
1189
0.420
Why?
Class I Phosphatidylinositol 3-Kinases
5
2021
67
0.410
Why?
Antimetabolites, Antineoplastic
4
2017
235
0.410
Why?
Hot Temperature
1
2013
210
0.410
Why?
Information Dissemination
1
2013
119
0.400
Why?
Publishing
1
2013
92
0.400
Why?
Hydroxyurea
12
2014
239
0.390
Why?
Health Status
1
2014
374
0.390
Why?
Adenocarcinoma, Bronchiolo-Alveolar
1
2011
20
0.380
Why?
Clinical Trials, Phase III as Topic
6
2022
170
0.380
Why?
Surveys and Questionnaires
6
2018
2721
0.380
Why?
Carcinoma, Large Cell
1
2011
39
0.380
Why?
Double-Blind Method
7
2021
1751
0.380
Why?
Periodicals as Topic
1
2013
167
0.370
Why?
Adenocarcinoma, Follicular
1
2012
55
0.370
Why?
Receptor, ErbB-2
5
2017
258
0.370
Why?
Radiation-Sensitizing Agents
2
2012
98
0.360
Why?
Benzimidazoles
1
2012
109
0.360
Why?
Sulfonamides
5
2016
327
0.360
Why?
Mitogen-Activated Protein Kinases
3
2008
229
0.360
Why?
Bevacizumab
6
2011
270
0.360
Why?
Thyroid Gland
1
2012
281
0.350
Why?
Radiotherapy Dosage
10
2016
472
0.340
Why?
Patient Care Team
1
2013
293
0.340
Why?
Disease Progression
10
2020
1504
0.340
Why?
Cohort Studies
8
2025
2972
0.330
Why?
Cyclin-Dependent Kinase Inhibitor p16
2
2022
105
0.330
Why?
Receptor Protein-Tyrosine Kinases
2
2011
159
0.330
Why?
Dose-Response Relationship, Drug
10
2017
1939
0.330
Why?
Clinical Trials, Phase II as Topic
4
2022
168
0.330
Why?
Proto-Oncogene Proteins c-ret
3
2016
22
0.320
Why?
Fluorodeoxyglucose F18
1
2010
142
0.320
Why?
Randomized Controlled Trials as Topic
6
2022
875
0.320
Why?
Mice
13
2021
12160
0.320
Why?
Immunohistochemistry
7
2020
1806
0.320
Why?
Diarrhea
4
2014
180
0.320
Why?
Animals
19
2021
28052
0.310
Why?
Protein Kinase C-alpha
1
2009
29
0.310
Why?
Skin
1
2012
591
0.300
Why?
Thalidomide
3
2015
56
0.300
Why?
Positron-Emission Tomography
1
2010
340
0.300
Why?
Proto-Oncogene Proteins B-raf
3
2016
154
0.300
Why?
Radiation Tolerance
4
2016
174
0.300
Why?
ras Proteins
3
2016
133
0.290
Why?
Pharmacogenetics
1
2012
448
0.290
Why?
Lymphocyte Activation
3
2020
788
0.290
Why?
Esophageal Neoplasms
3
2017
338
0.280
Why?
Radiotherapy
6
2020
325
0.280
Why?
DNA-Binding Proteins
4
2016
1250
0.280
Why?
United States
14
2020
7312
0.280
Why?
Medical Oncology
3
2018
392
0.280
Why?
Chemotherapy, Adjuvant
7
2021
485
0.270
Why?
Neoadjuvant Therapy
4
2024
400
0.270
Why?
Biopsy
3
2020
1197
0.270
Why?
Retreatment
5
2015
107
0.270
Why?
Niacinamide
5
2014
101
0.270
Why?
Protein Kinases
1
2008
215
0.270
Why?
Triazines
1
2007
54
0.270
Why?
DNA, Neoplasm
3
2017
267
0.260
Why?
Young Adult
11
2019
6597
0.260
Why?
Eating
1
2007
168
0.260
Why?
Time Factors
9
2020
5425
0.260
Why?
Xenograft Model Antitumor Assays
6
2021
498
0.260
Why?
Epidermal Growth Factor
1
2006
118
0.260
Why?
Retrospective Studies
16
2020
9619
0.250
Why?
Genomics
4
2015
804
0.250
Why?
Deoxycytidine
2
2011
212
0.250
Why?
Immunotoxins
1
2005
15
0.250
Why?
B-Lymphocytes
2
2021
754
0.250
Why?
Apoptosis
5
2023
1752
0.250
Why?
Vascular Endothelial Growth Factor Receptor-2
4
2015
80
0.250
Why?
Oligonucleotides, Antisense
1
2005
67
0.250
Why?
Ribosomal Protein S6 Kinases, 70-kDa
3
2018
47
0.250
Why?
Tongue Neoplasms
3
2017
51
0.250
Why?
Tumor Escape
3
2020
52
0.240
Why?
Immunologic Factors
3
2021
174
0.240
Why?
Protein Kinase C
1
2006
267
0.240
Why?
Viral Vaccines
2
2003
44
0.240
Why?
Drug Approval
2
2019
66
0.240
Why?
United States Food and Drug Administration
2
2019
136
0.240
Why?
Proto-Oncogene Proteins p21(ras)
2
2020
169
0.240
Why?
Fatigue
3
2016
178
0.230
Why?
Vinblastine
2
2002
100
0.230
Why?
Risk Factors
11
2019
5683
0.230
Why?
Genes, p53
2
2015
109
0.230
Why?
T-Lymphocytes
3
2020
1278
0.230
Why?
Phosphatidylinositol 3-Kinases
3
2015
277
0.220
Why?
Evidence-Based Dentistry
3
2017
10
0.220
Why?
Clinical Protocols
2
2014
159
0.220
Why?
Chromosome Deletion
2
2015
229
0.220
Why?
Receptor, ErbB-3
2
2021
19
0.220
Why?
Piperazines
3
2017
288
0.220
Why?
MicroRNAs
1
2009
573
0.220
Why?
Fluorine
1
2023
17
0.210
Why?
Cell Proliferation
5
2021
1717
0.210
Why?
Mitochondria
1
2007
599
0.210
Why?
Deglutition
3
2013
78
0.210
Why?
Smoking
5
2014
640
0.210
Why?
MAP Kinase Signaling System
2
2016
201
0.210
Why?
Platinum
5
2016
65
0.200
Why?
Alcohol Drinking
4
2013
276
0.200
Why?
Pilot Projects
2
2023
894
0.200
Why?
Biomarkers
6
2021
1833
0.200
Why?
Immunomodulation
2
2021
61
0.200
Why?
Follow-Up Studies
10
2018
3766
0.200
Why?
Carboplatin
6
2019
321
0.200
Why?
Neoplasms, Second Primary
3
2011
244
0.200
Why?
Pain Management
2
2015
149
0.200
Why?
Cell Cycle
3
2010
514
0.190
Why?
Magnetic Resonance Spectroscopy
1
2023
315
0.190
Why?
Lymphocytes, Tumor-Infiltrating
1
2023
149
0.190
Why?
Drug Monitoring
2
2019
118
0.190
Why?
Pemetrexed
2
2012
76
0.190
Why?
Adenoviridae
2
2003
349
0.190
Why?
Benzenesulfonates
3
2011
50
0.180
Why?
Deglutition Disorders
2
2016
121
0.180
Why?
Clinical Competence
2
2018
804
0.180
Why?
Mechanistic Target of Rapamycin Complex 1
1
2021
40
0.180
Why?
Gene Deletion
2
2014
351
0.180
Why?
Muscle Neoplasms
1
2001
17
0.180
Why?
Germ-Line Mutation
2
2022
356
0.180
Why?
Carcinoma
3
2015
437
0.180
Why?
Taxoids
2
2014
126
0.180
Why?
Immunogenicity, Vaccine
1
2020
13
0.180
Why?
Genetic Therapy
2
2012
376
0.180
Why?
Salvage Therapy
2
2016
233
0.180
Why?
Immune System
1
2021
102
0.180
Why?
Vaccines, Subunit
1
2020
55
0.180
Why?
Oncolytic Virotherapy
1
2020
42
0.170
Why?
Blood Pressure
3
2014
908
0.170
Why?
Radiotherapy, Intensity-Modulated
3
2019
180
0.170
Why?
Prospective Studies
6
2022
4457
0.170
Why?
Heterografts
2
2017
107
0.170
Why?
Rimantadine
1
2019
9
0.170
Why?
Paclitaxel
6
2012
495
0.170
Why?
Doxorubicin
1
2001
296
0.170
Why?
Quinolones
1
2020
57
0.170
Why?
Oncogene Proteins, Viral
1
2019
33
0.170
Why?
Clinical Trials, Phase I as Topic
3
2014
153
0.170
Why?
Leukoplakia, Oral
2
2024
12
0.160
Why?
Nomograms
1
2019
33
0.160
Why?
Age Factors
3
2019
1898
0.160
Why?
Melanoma
1
2024
481
0.160
Why?
Decision Support Techniques
1
2020
173
0.160
Why?
Models, Immunological
1
2019
84
0.150
Why?
Genotype
2
2015
1864
0.150
Why?
Drug Synergism
3
2018
311
0.150
Why?
CTLA-4 Antigen
1
2019
141
0.150
Why?
Brain Neoplasms
1
2024
799
0.150
Why?
Palliative Medicine
1
2018
11
0.150
Why?
Carcinoma, Neuroendocrine
3
2013
38
0.150
Why?
Chromosomes, Human, Pair 3
2
2015
54
0.150
Why?
Toll-Like Receptor 7
1
2017
8
0.140
Why?
Risk Assessment
6
2016
2358
0.140
Why?
Toll-Like Receptor 9
1
2017
20
0.140
Why?
Biological Products
1
2020
171
0.140
Why?
Cell Growth Processes
2
2009
85
0.140
Why?
Immunoglobulin G
1
2019
479
0.140
Why?
Administration, Intravenous
1
2017
59
0.140
Why?
Immune Tolerance
2
2019
354
0.140
Why?
Transforming Growth Factor alpha
2
2009
50
0.140
Why?
Confidence Intervals
4
2019
219
0.140
Why?
Mouth Mucosa
2
2009
68
0.140
Why?
Evidence-Based Medicine
2
2015
445
0.140
Why?
Consensus
1
2019
377
0.140
Why?
Gene Expression
2
2014
1318
0.140
Why?
Population Surveillance
2
2018
214
0.140
Why?
Models, Biological
3
2014
1784
0.140
Why?
Urinary Bladder Neoplasms
1
2001
372
0.140
Why?
Macrophages
2
2017
601
0.140
Why?
Base Sequence
3
2014
2332
0.140
Why?
Mice, Inbred C3H
1
2017
371
0.140
Why?
SOX9 Transcription Factor
1
2016
28
0.140
Why?
Class Ib Phosphatidylinositol 3-Kinase
1
2016
4
0.140
Why?
Proto-Oncogenes
1
2016
61
0.140
Why?
Pyrazines
2
2022
92
0.130
Why?
Predictive Value of Tests
2
2020
1762
0.130
Why?
Metformin
1
2018
132
0.130
Why?
Tomography, X-Ray Computed
3
2019
2686
0.130
Why?
Accessory Nerve Diseases
1
2016
1
0.130
Why?
Trismus
1
2016
5
0.130
Why?
Dental Caries
1
2016
4
0.130
Why?
Circulating Tumor DNA
1
2017
48
0.130
Why?
Respiratory Aspiration
1
2016
5
0.130
Why?
Xerostomia
1
2016
10
0.130
Why?
Taste Disorders
1
2016
9
0.130
Why?
Voice Disorders
1
2016
7
0.130
Why?
Periodontitis
1
2016
7
0.130
Why?
In Situ Hybridization, Fluorescence
3
2012
356
0.130
Why?
American Cancer Society
1
2016
13
0.130
Why?
Mass Screening
2
2012
667
0.130
Why?
Dental Care
1
2016
12
0.130
Why?
Stomatitis
1
2016
30
0.130
Why?
Benzamides
2
2022
239
0.130
Why?
Osteonecrosis
1
2016
21
0.130
Why?
Vestibular Neuronitis
1
2016
5
0.130
Why?
Neck Muscles
1
2016
17
0.130
Why?
Dystonia
1
2016
29
0.130
Why?
Bursitis
1
2016
14
0.130
Why?
Peptide Hormones
1
2016
30
0.130
Why?
Pyrimidinones
1
2016
39
0.130
Why?
Pyridones
1
2016
59
0.120
Why?
Proto-Oncogene Proteins
2
2010
679
0.120
Why?
Drug Evaluation, Preclinical
1
2015
108
0.120
Why?
Societies, Medical
1
2019
598
0.120
Why?
Collagen Type I
1
2015
73
0.120
Why?
Matrix Metalloproteinases
1
2015
30
0.120
Why?
Peripheral Nervous System Diseases
1
2016
92
0.120
Why?
Drug Screening Assays, Antitumor
2
2015
83
0.120
Why?
Pneumonia, Aspiration
1
2014
19
0.120
Why?
Sleep Apnea Syndromes
1
2016
107
0.120
Why?
Multivariate Analysis
3
2019
991
0.120
Why?
Receptors, IgG
1
2015
56
0.120
Why?
Lymphedema
1
2016
79
0.120
Why?
Sleep Wake Disorders
1
2016
121
0.120
Why?
Phosphorylation
2
2018
1140
0.110
Why?
Proteomics
2
2022
245
0.110
Why?
Ubiquitin-Activating Enzymes
1
2014
6
0.110
Why?
Cost-Benefit Analysis
2
2020
489
0.110
Why?
Health Promotion
1
2016
168
0.110
Why?
Stomach Neoplasms
1
2017
297
0.110
Why?
Autophagy-Related Protein 7
1
2014
12
0.110
Why?
Drug Interactions
3
2011
244
0.110
Why?
Sequestosome-1 Protein
1
2014
22
0.110
Why?
Gastroesophageal Reflux
1
2016
126
0.110
Why?
Tumor Virus Infections
1
2014
83
0.110
Why?
Heterocyclic Compounds, 3-Ring
1
2014
31
0.110
Why?
Education, Medical, Graduate
1
2018
408
0.110
Why?
Peptide Fragments
1
2016
466
0.110
Why?
Neoplasm Grading
1
2015
389
0.110
Why?
Quinoxalines
1
2014
50
0.110
Why?
Licensure
1
2013
6
0.110
Why?
Transcription Factors
2
2016
1681
0.110
Why?
Tissue Array Analysis
1
2014
127
0.110
Why?
Pediatrics
1
2018
365
0.110
Why?
DNA Primers
2
2014
547
0.110
Why?
Population Groups
1
2013
41
0.110
Why?
Peer Review
1
2013
22
0.110
Why?
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization
2
2013
79
0.110
Why?
Regression Analysis
2
2019
595
0.110
Why?
Focus Groups
1
2014
184
0.110
Why?
Anxiety
1
2016
324
0.110
Why?
Aminolevulinic Acid
1
2013
22
0.110
Why?
Erythropoiesis
1
2013
51
0.110
Why?
Hypothyroidism
1
2016
264
0.110
Why?
Statistics, Nonparametric
3
2009
304
0.110
Why?
CD8-Positive T-Lymphocytes
1
2017
625
0.110
Why?
Photosensitizing Agents
1
2013
52
0.110
Why?
Economics, Pharmaceutical
1
2013
10
0.110
Why?
Area Under Curve
5
2014
337
0.100
Why?
Breast Neoplasms
2
2017
3052
0.100
Why?
Italy
1
2013
109
0.100
Why?
Magnetics
1
2013
41
0.100
Why?
Interviews as Topic
1
2014
350
0.100
Why?
Antineoplastic Agents, Phytogenic
2
2012
275
0.100
Why?
Micelles
1
2013
51
0.100
Why?
Gastrostomy
1
2013
69
0.100
Why?
Stress, Psychological
1
2016
328
0.100
Why?
United Kingdom
1
2013
173
0.100
Why?
Citrus paradisi
1
2012
5
0.100
Why?
Magnetic Resonance Imaging
2
2023
3480
0.100
Why?
Photochemotherapy
1
2013
101
0.100
Why?
Gene Expression Profiling
3
2014
1475
0.100
Why?
Ketoconazole
1
2012
24
0.100
Why?
Qualitative Research
1
2014
321
0.100
Why?
Lymphopenia
1
2012
32
0.100
Why?
Dose-Response Relationship, Radiation
2
2009
187
0.100
Why?
Pyrimidines
2
2014
374
0.100
Why?
Platinum Compounds
1
2012
28
0.100
Why?
Intracellular Signaling Peptides and Proteins
1
2014
388
0.100
Why?
Sexual Partners
1
2013
102
0.100
Why?
DNA Repair
1
2014
366
0.100
Why?
Biopsy, Needle
1
2012
231
0.100
Why?
Hyperlipidemias
1
2012
92
0.100
Why?
Autophagy
1
2014
169
0.100
Why?
Colorectal Neoplasms
2
2011
1039
0.100
Why?
Depression
1
2016
525
0.100
Why?
RNA, Viral
1
2013
323
0.100
Why?
Radiography
2
2014
806
0.100
Why?
Peptides
1
2015
662
0.090
Why?
RNA, Small Interfering
2
2010
560
0.090
Why?
Bibenzyls
1
2011
2
0.090
Why?
Tumor Suppressor Protein p53
1
2014
429
0.090
Why?
Exanthema
1
2012
40
0.090
Why?
Lactams, Macrocyclic
1
2011
13
0.090
Why?
Nanoparticles
1
2013
168
0.090
Why?
Benzoquinones
1
2011
26
0.090
Why?
Valproic Acid
1
2011
24
0.090
Why?
Feasibility Studies
2
2019
793
0.090
Why?
Radiotherapy, Adjuvant
3
2008
302
0.090
Why?
Depsipeptides
1
2011
29
0.090
Why?
Hyperglycemia
1
2012
176
0.090
Why?
Tracheotomy
1
2011
18
0.090
Why?
Boronic Acids
1
2011
54
0.090
Why?
Hydroxamic Acids
1
2011
50
0.090
Why?
Carbazoles
1
2011
33
0.090
Why?
Bortezomib
1
2011
81
0.090
Why?
Psoriasis
1
2014
247
0.090
Why?
In Situ Nick-End Labeling
1
2011
122
0.090
Why?
Imatinib Mesylate
1
2011
127
0.090
Why?
HSP90 Heat-Shock Proteins
1
2011
47
0.090
Why?
Gene Expression Regulation, Neoplastic
3
2024
1311
0.090
Why?
Oligonucleotides
1
2011
92
0.090
Why?
Chemoprevention
1
2011
92
0.090
Why?
Cyclin D1
1
2010
84
0.090
Why?
Camptothecin
1
2011
198
0.090
Why?
Neoplasm Transplantation
1
2011
398
0.090
Why?
Probability
5
2009
357
0.090
Why?
Histone Deacetylase Inhibitors
1
2011
105
0.090
Why?
Sexual Behavior
1
2013
319
0.090
Why?
Speech
1
2010
88
0.080
Why?
Piperidines
1
2011
164
0.080
Why?
Airway Obstruction
1
2011
110
0.080
Why?
DNA Mutational Analysis
2
2015
532
0.080
Why?
Antigen-Presenting Cells
2
2021
142
0.080
Why?
Cell Cycle Proteins
2
2010
402
0.080
Why?
Thermography
1
2009
11
0.080
Why?
Transplantation, Heterologous
1
2010
368
0.080
Why?
Tumor Cells, Cultured
1
2011
1052
0.080
Why?
Cell Line
2
2011
2525
0.080
Why?
Mass Spectrometry
1
2010
198
0.080
Why?
Receptors, Growth Factor
1
2009
52
0.080
Why?
Biomedical Research
1
2013
404
0.080
Why?
Cyclin E
1
2009
28
0.080
Why?
Endpoint Determination
1
2009
57
0.080
Why?
Referral and Consultation
1
2012
353
0.080
Why?
Demography
1
2009
185
0.080
Why?
Radiotherapy, High-Energy
1
2008
49
0.080
Why?
Internship and Residency
1
2018
1076
0.080
Why?
Cell Survival
1
2011
1011
0.080
Why?
Amino Acid Sequence
2
2016
2082
0.070
Why?
Oligonucleotide Array Sequence Analysis
1
2010
697
0.070
Why?
Adolescent
6
2019
9488
0.070
Why?
Radiosurgery
1
2011
295
0.070
Why?
Research
1
2009
254
0.070
Why?
Analysis of Variance
2
2008
899
0.070
Why?
Economics, Medical
1
2007
6
0.070
Why?
Drug Packaging
1
2007
7
0.070
Why?
Molecular Sequence Data
2
2016
3035
0.070
Why?
Drug Labeling
1
2007
40
0.070
Why?
Carcinoma, Renal Cell
1
2011
342
0.070
Why?
Polymorphism, Genetic
1
2011
829
0.070
Why?
DNA
1
2012
1314
0.070
Why?
DNA, Mitochondrial
1
2007
189
0.070
Why?
Benzophenanthridines
1
2006
23
0.070
Why?
Butadienes
1
2006
34
0.070
Why?
Phenanthridines
1
2006
24
0.070
Why?
Phosphorylcholine
1
2006
29
0.070
Why?
Alkaloids
1
2006
46
0.070
Why?
Remission Induction
3
2016
762
0.070
Why?
Surgical Flaps
1
2008
254
0.060
Why?
Phenotype
1
2012
2498
0.060
Why?
Kidney Neoplasms
1
2011
530
0.060
Why?
Nitriles
1
2006
158
0.060
Why?
American Dental Association
2
2017
9
0.060
Why?
Keratinocytes
1
2006
148
0.060
Why?
Preoperative Care
2
2006
405
0.060
Why?
Cyclooxygenase Inhibitors
1
2004
39
0.060
Why?
Early Detection of Cancer
3
2017
466
0.060
Why?
Enzyme Activation
1
2006
700
0.060
Why?
Proteasome Inhibitors
1
2004
52
0.060
Why?
Hypoxia-Inducible Factor 1
1
2004
43
0.060
Why?
SEER Program
2
2016
226
0.060
Why?
Incidence
3
2017
1652
0.060
Why?
Mouthwashes
1
2003
5
0.060
Why?
Cell Transformation, Neoplastic
1
2006
461
0.050
Why?
Colonic Neoplasms
1
2008
580
0.050
Why?
DNA Copy Number Variations
2
2015
183
0.050
Why?
Hypoxia-Inducible Factor 1, alpha Subunit
1
2004
168
0.050
Why?
Mitogen-Activated Protein Kinase 3
1
2003
70
0.050
Why?
Vascular Endothelial Growth Factor Receptor-3
2
2015
26
0.050
Why?
Intubation, Gastrointestinal
1
2003
31
0.050
Why?
CCAAT-Enhancer-Binding Protein-beta
2
2016
13
0.050
Why?
Odds Ratio
2
2018
689
0.050
Why?
Infant
2
2023
3214
0.050
Why?
Disease Models, Animal
2
2020
2456
0.050
Why?
Infusions, Intravenous
3
2009
420
0.050
Why?
Isotretinoin
1
2002
20
0.050
Why?
Gene Amplification
2
2015
135
0.050
Why?
Vascular Endothelial Growth Factor Receptor-1
2
2015
99
0.050
Why?
Medicare
2
2016
437
0.050
Why?
Inflammation
2
2019
1020
0.050
Why?
Illinois
1
2003
503
0.050
Why?
Interferon-alpha
1
2002
214
0.050
Why?
Sex Factors
2
2014
1090
0.050
Why?
Cytodiagnosis
2
2012
46
0.050
Why?
Germany
1
2021
74
0.050
Why?
Lymphopoiesis
1
2021
48
0.040
Why?
Antibody Formation
1
2021
175
0.040
Why?
Structure-Activity Relationship
1
2001
432
0.040
Why?
Placebos
1
2021
211
0.040
Why?
Urothelium
1
2001
65
0.040
Why?
Standard of Care
1
2021
68
0.040
Why?
RAW 264.7 Cells
1
2019
18
0.040
Why?
Nuclear Proteins
1
2004
735
0.040
Why?
Treatment Adherence and Compliance
1
2019
5
0.040
Why?
Models, Economic
1
2020
63
0.040
Why?
Child
3
2018
7311
0.040
Why?
Thinness
1
2019
46
0.040
Why?
Employment
1
2019
53
0.040
Why?
Receptors, Cytokine
1
2019
29
0.040
Why?
Smokers
1
2019
50
0.040
Why?
Quality-Adjusted Life Years
1
2020
152
0.040
Why?
Healthy Volunteers
1
2019
146
0.040
Why?
Histocompatibility Antigens Class II
1
2019
168
0.040
Why?
Hospitals, Veterans
1
2018
22
0.040
Why?
Veterans
1
2019
89
0.040
Why?
Patient Reported Outcome Measures
1
2021
257
0.040
Why?
Epithelial Cells
1
2022
701
0.040
Why?
Equivalence Trials as Topic
1
2018
6
0.040
Why?
Training Support
1
2018
23
0.040
Why?
Interdisciplinary Studies
1
2018
20
0.040
Why?
Insulin-Like Growth Factor II
1
2018
33
0.040
Why?
Antigen Presentation
1
2019
217
0.040
Why?
Clinical Decision-Making
1
2020
287
0.040
Why?
Laryngectomy
1
2018
26
0.040
Why?
Organ Specificity
1
2019
283
0.040
Why?
Down-Regulation
1
2019
523
0.040
Why?
Drug-Related Side Effects and Adverse Reactions
1
2020
205
0.040
Why?
Herpesvirus 1, Human
1
2020
245
0.040
Why?
Mouth
1
2017
49
0.040
Why?
Insulin-Like Growth Factor I
1
2018
115
0.040
Why?
Enteral Nutrition
1
2018
104
0.040
Why?
Autoimmunity
1
2019
175
0.040
Why?
HEK293 Cells
1
2019
667
0.040
Why?
Reference Values
2
2009
661
0.040
Why?
Leukocytes, Mononuclear
1
2018
207
0.030
Why?
Neck Dissection
2
2008
67
0.030
Why?
Diagnostic Tests, Routine
1
2017
64
0.030
Why?
Acrylamides
1
2017
35
0.030
Why?
Regulatory-Associated Protein of mTOR
1
2016
11
0.030
Why?
MDS1 and EVI1 Complex Locus Protein
1
2016
7
0.030
Why?
Proportional Hazards Models
1
2019
873
0.030
Why?
Aniline Compounds
1
2017
61
0.030
Why?
Osteonectin
1
2016
22
0.030
Why?
Program Evaluation
1
2018
315
0.030
Why?
National Cancer Institute (U.S.)
1
2016
72
0.030
Why?
MCF-7 Cells
1
2016
117
0.030
Why?
Financing, Government
1
2016
24
0.030
Why?
Decision Making
1
2002
679
0.030
Why?
Immunoenzyme Techniques
1
2016
303
0.030
Why?
Loss of Heterozygosity
1
2016
86
0.030
Why?
Snake Venoms
1
2015
9
0.030
Why?
Comorbidity
1
2019
978
0.030
Why?
Bayes Theorem
1
2017
389
0.030
Why?
Exons
1
2017
455
0.030
Why?
Microfilament Proteins
1
2016
212
0.030
Why?
Acid Anhydride Hydrolases
1
2015
13
0.030
Why?
RNA Interference
1
2016
381
0.030
Why?
Cause of Death
1
2016
271
0.030
Why?
Human papillomavirus 18
1
2014
16
0.030
Why?
Cell Division
1
2016
699
0.030
Why?
Lymphatic Metastasis
1
2016
499
0.030
Why?
Biological Availability
1
2014
91
0.030
Why?
Nonlinear Dynamics
1
2014
73
0.030
Why?
Tissue Distribution
1
2014
295
0.030
Why?
Protein Interaction Maps
1
2014
51
0.030
Why?
Gene Knockout Techniques
1
2014
83
0.030
Why?
Transcription, Genetic
1
2019
1170
0.030
Why?
Anorexia
1
2014
28
0.030
Why?
Metabolic Clearance Rate
1
2014
119
0.030
Why?
Immunoblotting
1
2014
276
0.030
Why?
Erythrocyte Count
1
2013
22
0.030
Why?
Calcitonin
1
2013
38
0.030
Why?
Leg
1
2014
142
0.030
Why?
Carcinoembryonic Antigen
1
2013
41
0.030
Why?
Receptor, ErbB-4
1
2013
5
0.030
Why?
Cotinine
1
2013
15
0.030
Why?
Carrier Proteins
1
2016
683
0.030
Why?
Genetic Association Studies
1
2015
294
0.030
Why?
NF-kappa B
1
2016
470
0.030
Why?
Erythropoietin
1
2013
90
0.030
Why?
HeLa Cells
1
2014
518
0.030
Why?
Sensitivity and Specificity
1
2017
2015
0.030
Why?
Pyrazoles
1
2014
151
0.030
Why?
Microscopy, Atomic Force
1
2013
54
0.030
Why?
Sequence Analysis, RNA
1
2014
246
0.030
Why?
Risk Reduction Behavior
1
2013
97
0.030
Why?
Tolonium Chloride
1
2012
5
0.030
Why?
Herpesvirus 4, Human
1
2013
122
0.020
Why?
Saliva
1
2013
125
0.020
Why?
Coloring Agents
1
2012
65
0.020
Why?
Vomiting
1
2014
198
0.020
Why?
Microscopy, Confocal
1
2013
282
0.020
Why?
Asymptomatic Diseases
1
2012
45
0.020
Why?
Neoplasm Proteins
1
2015
546
0.020
Why?
Self Report
1
2013
307
0.020
Why?
Supraglottitis
1
2011
3
0.020
Why?
Chemoradiotherapy, Adjuvant
1
2011
37
0.020
Why?
Physical Examination
1
2012
151
0.020
Why?
Radiotherapy Planning, Computer-Assisted
1
2012
192
0.020
Why?
Cells, Cultured
1
2016
2911
0.020
Why?
Light
1
2012
294
0.020
Why?
Radiation Dosage
1
2011
231
0.020
Why?
Cross-Over Studies
1
2011
389
0.020
Why?
Review Literature as Topic
1
2010
22
0.020
Why?
Osteoradionecrosis
1
2010
18
0.020
Why?
Postoperative Period
1
2010
309
0.020
Why?
Mercury Compounds
1
2009
1
0.020
Why?
Cadmium Compounds
1
2009
2
0.020
Why?
ROC Curve
1
2012
786
0.020
Why?
Mice, Inbred C57BL
1
2016
3356
0.020
Why?
Laboratories
1
2009
44
0.020
Why?
Tight Junctions
1
2010
151
0.020
Why?
Hospitalization
1
2014
924
0.020
Why?
Nitrogen
1
2009
75
0.020
Why?
Cyclin D
1
2008
14
0.020
Why?
Gene Dosage
1
2009
211
0.020
Why?
Transcription Factor AP-1
1
2008
65
0.020
Why?
Infant, Newborn
1
2014
2517
0.020
Why?
Rats, Inbred F344
1
2008
154
0.020
Why?
Azoxymethane
1
2008
84
0.020
Why?
Cyclins
1
2008
82
0.020
Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2010
893
0.020
Why?
Equipment Design
1
2009
419
0.020
Why?
STAT3 Transcription Factor
1
2008
90
0.020
Why?
Temperature
1
2009
404
0.020
Why?
Technology, Radiologic
1
2008
104
0.020
Why?
Proto-Oncogene Proteins c-met
1
2009
200
0.020
Why?
Glioblastoma
1
2010
281
0.020
Why?
Transfection
1
2009
914
0.020
Why?
Protein Structure, Tertiary
1
2009
743
0.020
Why?
Child, Preschool
1
2014
3809
0.020
Why?
Barrett Esophagus
1
2008
95
0.020
Why?
Forecasting
1
2008
310
0.020
Why?
Organ Preservation
1
2008
131
0.020
Why?
Polymorphism, Single Nucleotide
1
2015
2446
0.020
Why?
Blotting, Western
1
2008
799
0.020
Why?
p38 Mitogen-Activated Protein Kinases
1
2006
126
0.020
Why?
Body Mass Index
1
2009
799
0.020
Why?
Phospholipids
1
2006
112
0.020
Why?
Genome, Human
1
2010
797
0.010
Why?
Pleural Effusion
1
2004
47
0.010
Why?
Organoplatinum Compounds
1
2004
95
0.010
Why?
RNA, Messenger
1
2010
2041
0.010
Why?
Administration, Topical
1
2003
95
0.010
Why?
Membrane Proteins
1
2010
1246
0.010
Why?
In Situ Hybridization
1
2003
314
0.010
Why?
Genome-Wide Association Study
1
2011
1719
0.010
Why?
Survival
1
2002
21
0.010
Why?
Severity of Illness Index
1
2008
1905
0.010
Why?
Rats
1
2008
4069
0.010
Why?
Case-Control Studies
1
2006
1891
0.010
Why?
Registries
1
2006
899
0.010
Why?
Cohen's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (656)
Explore
_
Co-Authors (56)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_